The Clorox Company (NYSE:CLX – Get Free Report)’s share price hit a new 52-week low on Monday . The stock traded as low as $126.40 and last traded at $126.81, with a volume of 171973 shares. The stock had previously closed at $127.69.
Analyst Ratings Changes
CLX has been the subject of several analyst reports. JPMorgan Chase & Co. dropped their price objective on Clorox from $151.00 to $144.00 and set a “neutral” rating for the company in a report on Tuesday, May 6th. Barclays cut their target price on Clorox from $134.00 to $129.00 and set an “underweight” rating on the stock in a report on Wednesday, May 7th. Citigroup lowered their target price on Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a report on Monday, April 14th. Wells Fargo & Company dropped their price target on Clorox from $145.00 to $142.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Finally, UBS Group lowered their price target on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a research report on Thursday, April 17th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $151.23.
Check Out Our Latest Stock Analysis on CLX
Clorox Stock Performance
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business’s quarterly revenue was down 8.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.71 EPS. Analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.
Insider Buying and Selling at Clorox
In related news, Director Pierre R. Breber bought 4,000 shares of the company’s stock in a transaction dated Wednesday, May 7th. The stock was purchased at an average cost of $136.57 per share, with a total value of $546,280.00. Following the transaction, the director now owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.57% of the company’s stock.
Institutional Trading of Clorox
Several large investors have recently bought and sold shares of CLX. Redwood Park Advisors LLC purchased a new position in Clorox during the 4th quarter valued at about $26,000. Millstone Evans Group LLC purchased a new position in shares of Clorox in the fourth quarter worth $31,000. Wood Tarver Financial Group LLC bought a new position in Clorox during the 4th quarter valued at about $31,000. Asset Planning Inc purchased a new stake in Clorox in the fourth quarter worth approximately $32,000. Finally, GKV Capital Management Co. Inc. bought a new stake in shares of Clorox in the fourth quarter worth $32,000. 78.53% of the stock is owned by institutional investors.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Which U.S. Towns See Economic Change First? [2025 Survey]
- 3 Fintech Stocks With Good 2021 Prospects
- As Oil Prices Rebound, These Stocks Could Fuel the Next Rally
- How to Calculate Inflation Rate
- Top 3 FOMO Stocks for 2025 With More Room to Run
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.